Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2024

Aug 7, 2024

30442_dirs_2024-08-07_1cb4660c-7084-4fc7-b5cc-01c593c827c8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2024-08-05

Reporting Person: BURWIG SUSAN E (Exec. VP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-05 Common Stock M 50000 $90.65 Acquired 57500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-05 Employee Stock Option (Right to Buy) $90.65 M 50000 Disposed 2024-08-05 Common Stock (50000) Direct
2024-08-05 Restricted Stock Unit $ A 10000 Acquired Common Stock (10000) Direct

Footnotes

F1: The option vested on August 5, 2019.

F2: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F3: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.